| General Information of DME (ID: DMEN349) |
| DME Name |
Cytochrome P450 102D1 (cyp102D1), Streptomyces avermitilis
|
| Gene Name |
cyp102D1
|
| Lineage |
Species: Streptomyces avermitilis (Click to Show/Hide the Complete Species Lineage)
Kingdom: .
Phylum: .
Class: .
Order: .
Family: .
Genus: .
Species: Streptomyces avermitilis
|
|
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME
|
|
|
|
|
|
|
| Full List of Drug(s) Metabolized by This DME |
|
Drugs in Phase 4 Clinical Trial
|
Click to Show/Hide the Full List of Drugs: 1 Drugs
|
Daidzein |
Drug Info
|
Phase 4 |
Dyslipidaemia
|
ICD11: 5C81
|
[1] |
|
|
|
|
|
|
| Full List of Metabolic Reactions (MR) Catalyzed by This DME |
|
|
|
|
|
|
|
|
| References |
| 1 |
Engineering of daidzein 3'-hydroxylase P450 enzyme into catalytically self-sufficient cytochrome P450. Microb Cell Fact. 2012 Jun 14;11:81.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
